Effects of Gelidium elegans on Weight and Fat Mass Reduction and Obesity Biomarkers in Overweight or Obese Adults: A Randomized Double-Blinded Study

被引:12
作者
Kim, Choon Ok [1 ,2 ]
Kim, Youn Nam [3 ]
Lee, Duk-Chul [4 ]
机构
[1] Yonsei Univ, Severance Hosp, Dept Clin Pharmacol, Seoul 03722, South Korea
[2] Yonsei Univ, Severance Hosp, Clin Trials Ctr, Seoul 03722, South Korea
[3] Yonsei Univ Hlth Syst, Severance Hosp, Clin Trials Ctr, Seoul 03722, South Korea
[4] Yonsei Univ, Coll Med, Dept Family Med, Seoul 03722, South Korea
来源
NUTRIENTS | 2019年 / 11卷 / 07期
关键词
Gelidium elegans; obese; overweight; weight; fat mass; ADIPOGENIC TRANSCRIPTION FACTORS; ACCUMULATION; 3T3-L1; ACIDS;
D O I
10.3390/nu11071513
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The edible seaweed Gelidium elegans (GEE) is known to inhibit adipocyte differentiation. However, there has been no report on its effects in humans. In this study, we investigated whether GEE reduces body weight or fat mass in obese or overweight individuals. A total of 78 participants were randomly assigned to the test (GEE extract 1000 mg/day) and placebo groups at a 1:1 ratio, and treated for 12 weeks. At six or 12 weeks after randomization, they were evaluated for anthropometric parameters, biomarkers, and body composition. Changes in body weight and fat mass between the two groups was significantly different, as determined using ANCOVA adjusted for baseline, calorie intake, and physical activity. Body weight and fat mass were significantly decreased by GEE after 12 weeks but increased in the placebo group. Moreover, although not significant, triglyceride levels tended to decrease after GEE intake. There was no significant difference in other laboratory biomarkers between the two groups. Taken together, these results suggested that GEE significantly reduced body weight, especially fat mass, in overweight or obese individuals.
引用
收藏
页数:16
相关论文
共 30 条
[1]   2011 Compendium of Physical Activities: A Second Update of Codes and MET Values [J].
Ainsworth, Barbara E. ;
Haskell, William L. ;
Herrmann, Stephen D. ;
Meckes, Nathanael ;
Bassett, David R., Jr. ;
Tudor-Locke, Catrine ;
Greer, Jennifer L. ;
Vezina, Jesse ;
Whitt-Glover, Melicia C. ;
Leon, Arthur S. .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2011, 43 (08) :1575-1581
[2]   Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline [J].
Apovian, Caroline M ;
Aronne, Louis J. ;
Bessesen, Daniel H. ;
McDonnell, Marie E. ;
Murad, M. Hassan ;
Pagotto, Uberto ;
Ryan, Donna H. ;
Still, Christopher D. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02) :342-362
[3]   Impaired antioxidant status and decreased dietary intake of antioxidants in patients with systemic lupus erythematosus [J].
Bae, SC ;
Kim, SJ ;
Sung, MK .
RHEUMATOLOGY INTERNATIONAL, 2002, 22 (06) :238-243
[4]   Obesity: global epidemiology and pathogenesis [J].
Blueher, Matthias .
NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (05) :288-298
[5]  
Choi J, 2016, J FOOD NUTR RES, V4, P448, DOI DOI 10.12691/JFNR-4-7-6
[6]   Gelidium elegans Regulates the AMPK-PRDM16-UCP-1 Pathway and Has a Synergistic Effect with Orlistat on Obesity-Associated Features in Mice Fed a High-Fat Diet [J].
Choi, Jia ;
Kim, Kui-Jin ;
Koh, Eun-Jeong ;
Lee, Boo-Yong .
NUTRIENTS, 2017, 9 (04)
[7]  
Committee IR, Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms
[8]   Lipins: Multifunctional Lipid Metabolism Proteins [J].
Csaki, Lauren S. ;
Reue, Karen .
ANNUAL REVIEW OF NUTRITION, VOL 30, 2010, 30 :257-272
[9]  
Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI [10.1172/JCI200523621, 10.1172/JCI23621]
[10]   WEIGHT LOSS PHARMACOTHERAPY: BRIEF SUMMARY OF THE CLINICAL LITERATURE AND COMMENTS ON RACIAL DIFFERENCES [J].
Egan, Brent M. ;
White, Kellee .
ETHNICITY & DISEASE, 2015, 25 (04) :511-514